top of page
Banner 2.jpeg

Solutions

Industries

Advanced Therapy Medicinal Products (ATMP) & Cell and Gene Therapies (CGT)

Overview

Advanced Therapy Medicinal Products (ATMP) and Cell and Gene Therapies (CGT) offer groundbreaking new opportunities for treating diseases and injuries using genes, tissues, or cells. Unlike traditional pharmaceutical facilities, which use closed and automated processes to manufacture high-volume batches of identical products, ATMP/CGT manufacturing is primarily a small-batch, operator-driven process.

To achieve efficient and cost-effective production, facilities must be flexible. This includes the ability to produce multiple products within the same facility and quickly adapt and integrate new technologies and processes. The critical endpoint in this complex process cycle for cell and gene therapy is packaging the liquid medicinal product into vials, syringes, or IV bags.

Our Vers-A-Tech™ machine meets the needs of ATMP and Cell and Gene Therapy processing. This innovative semi- or fully-automatic fill-finish line is designed to accelerate the packaging of bags and nested containers on one platform.

BioTechnology

Overview

Biopharmaceutical companies continue to focus on developing high-value, targeted therapies for smaller patient populations. Manufacturing operations are being re-engineered to meet the growing demands for producing small batches of precision medicines. Key trends in this segment include:

 -         Implementing continuous flow systems to enhance
            time efficiency, reduce costs, and ensure patient and
            product safety

 -         Increasing the use of single-use systems to minimize
            the risk of cross-contamination and decrease
            equipment downtime for cleaning

 -         Boosting flexibility to manufacture multiple products
            simultaneously, allowing for smaller batch sizes and
            rapid changeovers

The packaging requirements for biotech are complex, but we have the right solution for you. Our modular components are custom integrated to your specifications, featuring single-use fluid pathway kits, toolless change-over parts for various container sizes and types, and automation to safely process repetitive tasks.

Pharmaceuticals

Overview

The global pharmaceutical industry is experiencing increasing demand for proven vaccines and medicines, as well as a growing need for self-administered treatments via pre-filled syringes, auto-injectors, and wearable devices. Additionally, talent shortages and new treatment modalities are significantly impacting the manufacturing of these critical medicines.

Our fill-finish solutions are constantly evolving to adapt to the dynamic requirements of the pharmaceutical industry and, most importantly, to support our customers' operations. We collaborate closely with each client to overcome specific challenges and optimize their packaging processes. With 55 years of experience, we have successfully served a wide range of clients with varying needs in the pharmaceutical sector.

By integrating modular processing components, our solutions offer the flexibility to meet future demands and incorporate automation to ensure product safety and address labor shortages.

503B Manufacturing

Overview

The compounding industry is expanding rapidly in response to ongoing drug shortages and rising drug costs. 503B Outsourcing Facilities are increasing their processing capacity to meet the growing demand for ready-to-administer sterile compounded medicines. These facilities face complex processing requirements and need flexibility to handle various batch sizes and multiple products.

Let's explore how we can assist you.

Advanced Therapy Medicinal Products (ATMP) & Cell and Gene Therapies (CGT)

Overview

Advanced Therapy Medicinal Products (ATMP) and Cell and Gene Therapies (CGT) offer groundbreaking new opportunities for treating diseases and injuries using genes, tissues, or cells. Unlike traditional pharmaceutical facilities, which use closed and automated processes to manufacture high-volume batches of identical products, ATMP/CGT manufacturing is primarily a small-batch, operator-driven process.

Overview

Biopharmaceutical companies continue to focus on developing high-value, targeted therapies for smaller patient populations. Manufacturing operations are being re-engineered to meet the growing demands for producing small batches of precision medicines. Key trends in this segment include:

 -         Implementing continuous flow
            systems to enhance time
            efficiency, reduce costs, and
            ensure patient and product
            safety

 -         Increasing the use of single
            use systems to minimize the
            risk of cross-contamination
            and decrease equipment
            downtime for cleaning

 -         Boosting flexibility to
            manufacture multiple
            products simultaneously,
            allowing for smaller batch
            sizes and rapid changeovers

The packaging requirements for biotech are complex, but we have the right solution for you. Our modular components are custom integrated to your specifications, featuring single-use fluid pathway kits, toolless change-over parts for various container sizes and types, and automation to safely process repetitive tasks.
Industries We Serve

Pharmaceuticals

Overview

The global pharmaceutical industry is experiencing increasing demand for proven vaccines and medicines, as well as a growing need for self-administered treatments via pre-filled syringes, auto-injectors, and wearable devices. Additionally, talent shortages and new treatment modalities are significantly impacting the manufacturing of these critical medicines.

Our fill-finish solutions are constantly evolving to adapt to the dynamic requirements of the pharmaceutical industry and, most importantly, to support our customers' operations. We collaborate closely with each client to overcome specific challenges and optimize their packaging processes. With 55 years of experience, we have successfully served a wide range of clients with varying needs in the pharmaceutical sector.

By integrating modular processing components, our solutions offer the flexibility to meet future demands and incorporate automation to ensure product safety and address labor shortages.

BioTechnology

Overview

The compounding industry is expanding rapidly in response to ongoing drug shortages and rising drug costs. 503B Outsourcing Facilities are increasing their processing capacity to meet the growing demand for ready-to-administer sterile compounded medicines. These facilities face complex processing requirements and need flexibility to handle various batch sizes and multiple products.

503B
Manufacturing

bottom of page